Biotech trio’s NASDAQ debuts push year’s IPO haul past $13B

Berkeley Lights caps off $178M raise with a nearly 200% stock gain

A trio of biotechs raised about $475 million in their public debuts late Thursday, bringing the total IPO cash raised in 2020 to $13.3 billion across 56 biopharma offerings. Berkeley Lights led the group with a $178.2 million raise, and a

Read the full 411 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers